IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285166 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Michael P Crawford und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Iowa Health Care, Iowa City, Iowa, United States of America. Hauptthemen laut MEDLINE: Interleukin-17, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: CSRD VA, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
CD4 + T-helper 17 (Th17) T cells are a key population in protective immunity during infection and in self-tolerance/autoimmunity. Through the secretion of IL-17, Th17 cells act in promotion of inflammation and are thus a major potential therapeutic target in autoimmune disorders. Recent reports have brought to light that the IL-17 family cytokines, IL-17A, IL-17F and IL-17AF, can directly act on CD4 + T-cells, both in murine and human systems, inducing functional changes in these cells. Here we show that this action is preferentially targeted toward naïve, but not memory, CD4 + T-cells. Naïve cells showed transcriptome changes as early as 48 hours post-IL-17 exposure, whereas memory cells remained unaffected as late as 7 days. These functional differences occurred despite similar IL-17 receptor expression on these subsets and were maintained in co-culture/transwell systems, with each subset maintaining its functional response to IL-17. Importantly, there were differences in downstream transcriptional signaling by the three IL-17 cytokines, with the IL-17AF heterodimer conferring both the greatest transcriptional change and most altered functional consequences. Detailed transcriptome analysis provides important insights into the genes and pathways that are modulated as a result of IL-17-mediated signaling and may serve as targets of future therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Iowa Health Care, Iowa City, Iowa, United States of America.
- Iowa City Veterans Administration Medical Center, Iowa City, IA, United States of America.
ORCID-Profile: Nitin J Karandikar
Förderung
- CSRD VA
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- U.S. Department of Veterans Affairs
- NIH NCI
Zitieren
APA
Crawford, M. P., Borcherding, N., & Karandikar, N. J. (2023). IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes. PLOS ONE. https://doi.org/10.1371/journal.pone.0285166
Vancouver
Crawford MP, Borcherding N, Karandikar NJ. IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes. PLOS ONE. 2023. doi:10.1371/journal.pone.0285166
BibTeX
@article{Crawford2023,
author = {Crawford, Michael P and Borcherding, Nicholas and Karandikar, Nitin J},
title = {IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285166}
}
EUVIMED